MX2011007165A - Derivados de piridazinona. - Google Patents

Derivados de piridazinona.

Info

Publication number
MX2011007165A
MX2011007165A MX2011007165A MX2011007165A MX2011007165A MX 2011007165 A MX2011007165 A MX 2011007165A MX 2011007165 A MX2011007165 A MX 2011007165A MX 2011007165 A MX2011007165 A MX 2011007165A MX 2011007165 A MX2011007165 A MX 2011007165A
Authority
MX
Mexico
Prior art keywords
pyridazinone derivatives
kinase inhibitors
compounds
pyridazinone
derivatives
Prior art date
Application number
MX2011007165A
Other languages
English (en)
Inventor
Dieter Dorsch
Oliver Schadt
Frank Stieber
Andree Blaukat
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of MX2011007165A publication Critical patent/MX2011007165A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A61K31/501—Pyridazines; Hydrogenated pyridazines not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Los compuestos de la fórmula I. Ver fórmula (I) en donde D, R1, R2, R3, R4 tienen los significados indicados en la reivindicación 1, son inhibidores de las tirosina cinasas, en especial de la Met-cinasa, y pueden utilizarse, por ejemplo, para el tratamiento de tumores.
MX2011007165A 2009-01-07 2009-12-10 Derivados de piridazinona. MX2011007165A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102009003954A DE102009003954A1 (de) 2009-01-07 2009-01-07 Pyridazinonderivate
PCT/EP2009/008840 WO2010078910A1 (de) 2009-01-07 2009-12-10 Pyridazinonderivate

Publications (1)

Publication Number Publication Date
MX2011007165A true MX2011007165A (es) 2011-08-04

Family

ID=41719075

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2011007165A MX2011007165A (es) 2009-01-07 2009-12-10 Derivados de piridazinona.

Country Status (24)

Country Link
US (2) US8853211B2 (es)
EP (1) EP2373644B1 (es)
JP (1) JP2012514613A (es)
KR (1) KR101674695B1 (es)
CN (1) CN102272125B (es)
AR (1) AR075122A1 (es)
AU (1) AU2009336852B2 (es)
BR (1) BRPI0923913B1 (es)
CA (1) CA2748911C (es)
CY (1) CY1113698T1 (es)
DE (1) DE102009003954A1 (es)
DK (1) DK2373644T3 (es)
EA (1) EA019322B1 (es)
ES (1) ES2396301T3 (es)
HR (1) HRP20120979T1 (es)
IL (1) IL213828A (es)
MX (1) MX2011007165A (es)
PL (1) PL2373644T3 (es)
PT (1) PT2373644E (es)
SG (1) SG172421A1 (es)
SI (1) SI2373644T1 (es)
SM (1) SMT201300004B (es)
WO (1) WO2010078910A1 (es)
ZA (1) ZA201105780B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102009003954A1 (de) * 2009-01-07 2010-07-08 Merck Patent Gmbh Pyridazinonderivate
DE102009004061A1 (de) * 2009-01-08 2010-07-15 Merck Patent Gmbh Pyridazinonderivate
CN102731409A (zh) * 2011-04-08 2012-10-17 中国科学院上海药物研究所 一类哒嗪酮类化合物，其药物组合物、制备方法及用途
CN108463109B (zh) 2015-12-22 2022-04-29 先正达参股股份有限公司 杀有害生物活性吡唑衍生物
TWI795381B (zh) 2016-12-21 2023-03-11 比利時商健生藥品公司 作為ｍａｌｔ１抑制劑之吡唑衍生物
KR102476708B1 (ko) 2017-11-01 2022-12-09 삼성전자주식회사 광학 필터, 및 이를 포함하는 카메라 모듈 및 전자 장치
KR102673362B1 (ko) * 2018-03-27 2024-06-05 삼성전자주식회사 근적외선 흡수 필름, 광학 필터 및 전자 장치
CN108752322A (zh) * 2018-09-12 2018-11-06 广州新民培林医药科技有限公司 一种新型Tepotinib衍生物和制备方法及其在抗肿瘤药物中的应用
EP3953345B1 (en) 2019-04-11 2023-04-05 Janssen Pharmaceutica NV Pyridine rings containing derivatives as malt1 inhibitors
CN115583939A (zh) * 2022-11-04 2023-01-10 苏州莱安医药化学技术有限公司 一种特泊替尼中间体的合成方法

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5795964A (en) 1980-12-04 1982-06-15 Morishita Seiyaku Kk Preparation of 2-substituted-3(2h)-pyridazinone derivative
US4397854A (en) 1981-05-14 1983-08-09 Warner-Lambert Company Substituted 6-phenyl-3(2H)-pyridazinones useful as cardiotonic agents
AU691673B2 (en) 1994-11-14 1998-05-21 Dow Agrosciences Llc Pyridazinones and their use as fungicides
US5635494A (en) 1995-04-21 1997-06-03 Rohm And Haas Company Dihydropyridazinones and pyridazinones and their use as fungicides and insecticides
GB9624482D0 (en) 1995-12-18 1997-01-15 Zeneca Phaema S A Chemical compounds
JP4471404B2 (ja) 1996-02-13 2010-06-02 アストラゼネカ ユーケイ リミテッド Ｖｅｇｆインヒビターとしてのキナゾリン誘導体
ATE211134T1 (de) 1996-03-05 2002-01-15 4-anilinochinazolin derivate
GB9718972D0 (en) 1996-09-25 1997-11-12 Zeneca Ltd Chemical compounds
GB9714249D0 (en) 1997-07-08 1997-09-10 Angiogene Pharm Ltd Vascular damaging agents
KR100626605B1 (ko) 1997-11-19 2006-09-22 코와 가부시키가이샤 신규 피리다진 유도체 및 이를 유효성분으로 하는 의약
TWI241295B (en) 1998-03-02 2005-10-11 Kowa Co Pyridazine derivative and medicine containing the same as effect component
GB9900334D0 (en) 1999-01-07 1999-02-24 Angiogene Pharm Ltd Tricylic vascular damaging agents
GB9900752D0 (en) 1999-01-15 1999-03-03 Angiogene Pharm Ltd Benzimidazole vascular damaging agents
NZ522074A (en) 2000-05-31 2004-06-25 Astrazeneca Ab Indole derivatives with vascular damaging activity
JP2004502766A (ja) 2000-07-07 2004-01-29 アンギオジェン・ファーマシューティカルズ・リミテッド 血管損傷剤としてのコルヒノール誘導体
CA2410562A1 (en) 2000-07-07 2002-01-31 Angiogene Pharmaceuticals Limited Colchinol derivatives as angiogenesis inhibitors
CZ2004516A3 (cs) 2001-10-31 2004-08-18 Merckápatentágmbh Inhibitor fosfodiesterázy typu @Ź jeho kombinace s jinými drogami a jeho použití
DE102005057924A1 (de) 2005-12-05 2007-06-06 Merck Patent Gmbh Pyridazinonderivate
DK1959955T3 (da) 2005-12-05 2011-02-07 Pfizer Prod Inc Fremgangsmåde til behandling af abnorm cellevækst
DE102006037478A1 (de) 2006-08-10 2008-02-14 Merck Patent Gmbh 2-(Heterocyclylbenzyl)-pyridazinonderivate
US8340070B2 (en) * 2006-10-03 2012-12-25 Qualcomm Incorporated Resource partitioning for wireless communication systems
DE102007025717A1 (de) * 2007-06-01 2008-12-11 Merck Patent Gmbh Arylether-pyridazinonderivate
DE102007025718A1 (de) * 2007-06-01 2008-12-04 Merck Patent Gmbh Pyridazinonderivate
DE102007032507A1 (de) * 2007-07-12 2009-04-02 Merck Patent Gmbh Pyridazinonderivate
DE102007061963A1 (de) 2007-12-21 2009-06-25 Merck Patent Gmbh Pyridazinonderivate
DE102008062826A1 (de) * 2008-12-23 2010-07-01 Merck Patent Gmbh Pyridazinonderivate
DE102009003954A1 (de) * 2009-01-07 2010-07-08 Merck Patent Gmbh Pyridazinonderivate

Also Published As

Publication number Publication date
CN102272125B (zh) 2014-01-08
KR101674695B1 (ko) 2016-11-09
SI2373644T1 (sl) 2013-02-28
KR20110105848A (ko) 2011-09-27
CA2748911C (en) 2017-05-16
BRPI0923913B1 (pt) 2021-05-25
IL213828A0 (en) 2011-07-31
PT2373644E (pt) 2013-01-14
WO2010078910A1 (de) 2010-07-15
EA201101041A1 (ru) 2012-01-30
US20110269765A1 (en) 2011-11-03
IL213828A (en) 2014-03-31
SMT201300004B (it) 2013-03-08
EP2373644A1 (de) 2011-10-12
EP2373644B1 (de) 2012-10-24
AU2009336852A1 (en) 2011-08-18
BRPI0923913A2 (pt) 2020-08-11
DE102009003954A1 (de) 2010-07-08
CN102272125A (zh) 2011-12-07
CA2748911A1 (en) 2010-07-15
CY1113698T1 (el) 2016-06-22
SG172421A1 (en) 2011-07-28
DK2373644T3 (da) 2012-12-10
AR075122A1 (es) 2011-03-09
ES2396301T3 (es) 2013-02-20
JP2012514613A (ja) 2012-06-28
HK1164853A1 (en) 2012-09-28
US20140148463A1 (en) 2014-05-29
US8853211B2 (en) 2014-10-07
HRP20120979T1 (hr) 2012-12-31
EA019322B1 (ru) 2014-02-28
PL2373644T3 (pl) 2013-03-29
AU2009336852B2 (en) 2015-10-29
US9376426B2 (en) 2016-06-28
ZA201105780B (en) 2012-04-25

Similar Documents

Publication Publication Date Title
MY153727A (en) Pyridazinone derivatives
MY155719A (en) 2-benzylpyridazinone derivatives as met kinase inhibitors
MX2009013077A (es) Derivados dde benzoxazolona.
MX2011007165A (es) Derivados de piridazinona.
MX2009012708A (es) Derivados de piridazinona.
MX2009012709A (es) Derivados de arileter-piridazinona.
MX2010003366A (es) Derivados de piperidina y piperazina para el tratamiento de tumores.
EA201100966A1 (ru) Производные пиридазинона
WO2008017361A3 (de) 2-(heterocyclylbenzyl)-pyridazinonderivate
UA99311C2 (en) Inhibitors of c-fms kinase
GEP20135785B (en) Pyrrolopyrimidine compounds as cdk inhibitors
EP2170337A4 (en) NEW TRIAZOLOPYRIDAZINE
EA201001648A1 (ru) Производные пиридазинона
MX344335B (es) Derivados de benzonitrilo como inhibidores de cinasa.
MX2009013341A (es) Derivados de 6-(pirrolopiridinil)-pirimidinil-2-amina.
MX2010003365A (es) Derivados de tiazol para el tratamiento de cancer.
EA201100334A1 (ru) Бициклические производные триазола для лечения опухолей
WO2009156041A3 (de) Thiazolyl-piperidinderivate
MX2009013515A (es) Derivados de 7-alquinil-1,8-naftiridonas, su preparacion y su aplicacion en terapeutica.
PH12012501125A1 (en) 3, 4, 4a, 10b - tetrahydro -1h- thiopyrano -[4, 3-c] isoquinoline derivatives
MX2016007810A (es) Derivados de n1-(3,3,3-trifluoro-2-hidroxo-2-metilpropionil)-piper idina como inhibidores de piruvato deshidrogenasa cinasa.
MX2011007232A (es) Derivados de benzotiazolona.
MX2009009916A (es) Tetrahidroquinolinas sustituidas.
MX2011012522A (es) Inhibidores de pirazol sustituido de proteina cinasa c-met.
UA106628C2 (uk) Метилпіролопіримідинкарбоксаміди

Legal Events

Date Code Title Description
FG Grant or registration